S. J. Hullegie, J. E. Arends, B. J. A. Rijnders, W. L. Irving, D

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Twelve years of dengue surveillance in Belgian travellers and significant increases in the number of cases in 2010 and 2013 J. Verschueren, L. Cnops,

Evolution of the incidence of hepatitis B virus infection and immunization rates in a large French cohort born between 1960 and 1994 C. Ramière, L. Roche,

Gut bacterial microbiota and obesity

I.J. Schalk Clinical Microbiology and Infection

Approach to diagnosis of infective endocarditis

Incidence and outcome of Staphylococcus aureus endocarditis—a 10-year single-centre northern European experience H. Asgeirsson, A. Thalme, M. Kristjansson,

O.J. Dyar, G. Tebano, C. Pulcini Clinical Microbiology and Infection

D. Khalil, M. Hultin, M.U. Rashid, B. Lund

Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis T. Steinmetz, N.

Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications T.-L. Liao, Y.-M.

Migrant health—a cause for concern?

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals G. Ippolito Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

Hepatitis B and C virus-related carcinogenesis

Infectious causes of cancer: an evolving educational saga

Virological tools to diagnose and monitor hepatitis C virus infection

Refugee crisis and re-emergence of forgotten infections in Europe

Treatment of complicated skin and skin structure infections in areas with low incidence of antibiotic resistance—a retrospective population based study.

A.E. Muller, U. Theuretzbacher, J.W. Mouton

D. Lippi, J.P. D'Elios, S. Caini Clinical Microbiology and Infection

Louis Pasteur, from crystals of life to vaccination

Dermatitis by Dermatophilus congolensis

Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013 L.E.B. Nabarro, R.A. Lever, M. Armstrong,

Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice? T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt

Prevalence of Toscana virus antibodies in residents of Croatia

Trends in length of stay, mortality and readmission among patients with community- acquired bacteraemia M. Søgaard, R.W. Thomsen, R.B. Bang, H.C. Schønheyder,

Use of whole genome sequencing in the Dutch Acute HCV in HIV study: focus on transmitted antiviral resistance M.T. Christiansen, S.J. Hullegie, M. Schutten,

Impact of antibiotic restrictions: the pharmaceutical perspective

Vector control: a cornerstone in the malaria elimination campaign

D. Lippi, J.P. D'Elios, S. Caini Clinical Microbiology and Infection

Training for the infectious diseases speciality in Norway

Laboratory diagnosis and biosafety issues of biological warfare agents

C. Fabrizio, A. Procopio Clinical Microbiology and Infection

Hepatitis C virus and interferon type III (interferon-λ3/interleukin-28B and interferon-λ4): genetic basis of susceptibility to infection and response.

Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman Clinical.

Effects of gentamicin monotherapy for the initial treatment of community-onset complicated non-obstructive acute pyelonephritis due to Enterobacteriaceae.

I. Al Shukri, F. Hamilton, M. Evans, S. Cooper, G. McKenzie, L

Elements of design: the knowledge on which we build

Levofloxacin in the treatment of ventilator-associated pneumonia

R. Bitterman, M. Paul, D. Polak, Y. Geffen

Metagenomics and probiotics

Hepatitis B and C virus-related carcinogenesis

Previously unknown species of Aspergillus

Laboratory diagnosis of Clostridium difficile disease

Sexually acquired Zika virus: a systematic review

Systematic review of antibiotic consumption in acute care hospitals

Abstracts cont. Clinical Microbiology and Infection

M. Daudin, P. Tattevin, B. Lelong, E. Flecher, S. Lavoué, C. Piau, A

R. Slinger, I. Moldovan, N. Barrowman, F. Chan

Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection E. Knops, E. Heger Clinical Microbiology.

C. Tamalet, P. Colson, E. Decroly, C. Dhiver, I. Ravaux, A. Stein, D

H. Leblebicioglu, C. Eroglu Clinical Microbiology and Infection

Clinical infection services—the Leiden experience

S. M. Bartsch, J. A. McKinnell, L. E. Mueller, L. G. Miller, S. K

Dynamics of hepatitis B virus quasispecies heterogeneity in association with nucleos(t)ide analogue treatment determined by MALDI-TOF MS M. Rybicka,

Increasing numbers of hospitalizations and deaths with mention of Clostridium difficile infection, north-eastern Italy, 2008–2013 U. Fedeli, E. Schievano,

M.T. Pérez-Rodríguez, A. Sousa, P. Martínez-Cueto, A. Ocampo

Survival of rhinoviruses on human fingers

Virology: a scientific discipline facing new challenges

Modelling during an emergency: the 2009 H1N1 influenza pandemic

R. Khatib, G. Simeunovic, M. Sharma, M. G. Fakih, L. B. Johnson, L

J.L. Balcázar Clinical Microbiology and Infection

Great oaks from little acorns grow—21 years of CMI

Impact of antibiotic restrictions: the patient's perspective

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Current knowledge and future perspectives on acute hepatitis C infection S.J. Hullegie, J.E. Arends, B.J.A. Rijnders, W.L. Irving, D. Salmon, M. Prins, A.M. Wensing, P. Klenerman, H. Leblebicioglu, C. Boesecke, J.K. Rockstroh, A.I.M. Hoepelman Clinical Microbiology and Infection Volume 21, Issue 8, Pages 797.e9-797.e17 (August 2015) DOI: 10.1016/j.cmi.2015.03.026 Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 1 Possible future treatment for acute hepatitis C virus infection treatment and response prognosis. pegIFN, pegylated interferon; SVR, sustained viral response. Clinical Microbiology and Infection 2015 21, 797.e9-797.e17DOI: (10.1016/j.cmi.2015.03.026) Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions